Cancer Patients Fly Free!

Corporate Angel Network is the only charitable organization in the United States whose sole mission is to help cancer patients access the best possible treatment for their specific type of cancer by arranging free travel to treatment across the country using empty seats on corporate jets. This not only improves the patients' chances of survival but at the same time, it reduces their emotional stress, physical discomfort and financial burden. 

Thanks to the generous cooperation of 500 of America's top corporations, including half of the top 100 in the Fortune 500, Corporate Angel network has coordinated more than 35,000 flights since its founding in 1981. The program offers an obvious and meaningful benefit to cancer patients along with the opportunity for companies with corporate aircraft to provide a wonderful community service by merging business activities with corporate social responsibility. 

http://www.corpangelnetwork.org

Data From Three Million Children under 20 yrs in 5 States Shows 23% Increase in Diabetes

Jeffrey Brewer, president and CEO of JDRF, issued the following statement today in response to a new study showing an increase in T1D among young people in the United States. According to the latest SEARCH for Diabetes in Youth data by the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH), the prevalence of T1D in people under age 20 rose by 23 percent between 2001 and 2009.

“This alarming growth in T1D, if unabated, means the prevalence of the disease would double for every future generation, resulting in massive new health care spending in federal entitlement programs and the private health care market,” said Mr. Brewer. “But even as the T1D rate rises, researchers funded by JDRF and other private foundations, coupled with federal initiatives like the Special Diabetes Program, are making remarkable strides across an array of diabetes research frontiers, from treatments to reverse vision loss, to technology like the artificial pancreas, to vaccines, and to new forms of insulin. ……read more at JDRF.org